Pearls and pitfalls in clinical interpretation of prostate-specific membrane antigen (PSMA)-targeted PET imaging

S Sheikhbahaei, A Afshar-Oromieh, M Eiber… - European journal of …, 2017 - Springer
Background The rapidly expanding clinical adaptation of prostate-specific membrane
antigen (PSMA)-targeted PET imaging in the evaluation of patients with prostate cancer has …

Targeting PSMA by radioligands in non-prostate disease—current status and future perspectives

P Backhaus, B Noto, N Avramovic, LS Grubert… - European journal of …, 2018 - Springer
Background Prostate-specific membrane antigen (PSMA) is the up-and-coming target for
molecular imaging of prostate cancer. Despite its name, non-prostate-related PSMA …

Prostate-specific membrane antigen (PSMA)-targeted PET imaging of prostate cancer: an update on important pitfalls

S Sheikhbahaei, RA Werner, LB Solnes… - Seminars in nuclear …, 2019 - Elsevier
The continuing adoption of prostate specific membrane antigen (PSMA)-targeted PET for
prostate cancer molecular imaging requires imagers and clinicians alike to be aware of the …

Comprehensive evaluation of prostate specific membrane antigen expression in the vasculature of renal tumors: implications for imaging studies and prognostic role

S Spatz, Y Tolkach, K Jung, C Stephan… - The Journal of …, 2018 - auajournals.org
Purpose: Prostate specific membrane antigen is expressed by the endothelium of many
tumors. The aim of the study was to find a rationale for prostate specific membrane antigen …

Reproducibility of PSMA PET/CT imaging for primary staging of treatment-naïve prostate cancer patients depends on the applied radiotracer: a retrospective study

MJ Hagens, DE Oprea-Lager, AN Vis… - Journal of Nuclear …, 2022 - Soc Nuclear Med
Our purpose was to determine and compare the interobserver variability of 3 clinically
frequently used radiotracers targeting the prostate-specific membrane antigen (PSMA) …

Bone Uptake in Prostate Cancer Patients: Diagnostic Performances of PSMA-RADS v1. 0, Clinical, Biological, and: 68: Ga-PSMA-11 PET Features to Predict …

A Letang, A Crombé, C Rousseau… - Clinical Nuclear …, 2022 - journals.lww.com
Purpose 68 Gallium-labeled prostate-specific membrane antigen-11 (PSMA) PET/CT is the
new reference to identify relapse during biochemical recurrence of prostate cancer (PCa) …

A practical guide to the pearls and pitfalls of PSMA PET imaging

AF Voter, RA Werner, H Savas, A Gafita… - Seminars in Nuclear …, 2024 - Elsevier
Prostate-specific membrane antigen (PSMA)-targeted PET agents have revolutionized the
care of patients with prostate cancer, supplanting traditional methods of imaging prostate …

Molecular and cellular complexity of glioma. Focus on tumour microenvironment and the use of molecular and imaging biomarkers to overcome treatment resistance

S Valtorta, D Salvatore, P Rainone, S Belloli… - International Journal of …, 2020 - mdpi.com
This review highlights the importance and the complexity of tumour biology and
microenvironment in the progression and therapy resistance of glioma. Specific gene …

Nonspecific uptake of 68Ga-prostate-specific membrane antigen in diseases other than prostate malignancy on positron emission tomography/computed tomography …

D Malik, A Sood, BR Mittal, H Singh… - Indian Journal of …, 2018 - journals.lww.com
Abstract 68 Ga-labeled prostate-specific membrane antigen (PSMA) ligand positron
emission tomography/computed tomography imaging (PET/CT) is a rapidly evolving imaging …

Recent advances in PET probes for hepatocellular carcinoma characterization

L Filippi, O Schillaci, O Bagni - Expert Review of Medical Devices, 2019 - Taylor & Francis
ABSTRACT Introduction: Positron Emission Tomography (PET) with 18F-
fluorodeoxyglucose (FDG) presents some limitations for imaging of hepatocellular …